{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:55:54Z","timestamp":1792108554752,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1994,11,1]],"date-time":"1994-11-01T00:00:00Z","timestamp":783648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Anaesth"],"published-print":{"date-parts":[[1994,11]]},"DOI":"10.1007\/bf03015662","type":"journal-article","created":{"date-parts":[[2009,5,2]],"date-time":"2009-05-02T04:20:17Z","timestamp":1241238017000},"page":"1104-1112","source":"Crossref","is-referenced-by-count":45,"title":["Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency"],"prefix":"10.1007","volume":"41","author":[{"given":"Jean-Fran\u00e7ois","family":"Hardy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"B\u00e9lisle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03015662_CR1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/1053-0770(91)90052-U","volume":"6","author":"D Royston","year":"1992","unstructured":"Royston D. High-dose aprotinin therapy: a review of the first five years\u2019 experience. J Cardiothorac Vasc Anesth 1992; 6: 76\u2013100.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"BF03015662_CR2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF03009046","volume":"39","author":"J-F Hardy","year":"1992","unstructured":"Hardy J-F, Desroches J. Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth 1992; 39: 353\u201365.","journal-title":"Can J Anaesth"},{"key":"BF03015662_CR3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0003-4975(93)90149-C","volume":"55","author":"S Westaby","year":"1993","unstructured":"Westaby S. Aprotinin in perspective. Ann Thorac Surg 1993; 55: 1033\u201341.","journal-title":"Ann Thorac Surg"},{"key":"BF03015662_CR4","doi-asserted-by":"crossref","first-page":"Sxlv","DOI":"10.1007\/BF03006273","volume":"37","author":"MM Cohen","year":"1990","unstructured":"Cohen MM. Using epidemiology to study adverse outcomes in anaesthesia. Can J Anaesth 1990; 37: Sxlv-Sxlviii.","journal-title":"Can J Anaesth"},{"key":"BF03015662_CR5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0003-4975(10)63153-0","volume":"28","author":"CJ Lambert","year":"1979","unstructured":"Lambert CJ, Marengo-Rowe AJ, Leveson JE, et al. The treatment of postperfusion bleeding using \u03b5-aminocaproic acid, cryoprecipitate, fresh-frozen plasma, and protamine sulfate. Ann Thorac Surg 1979; 28: 440\u20134.","journal-title":"Ann Thorac Surg"},{"key":"BF03015662_CR6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0022-5223(19)35778-2","volume":"95","author":"Salm TJ Vander","year":"1988","unstructured":"Vander Salm TJ, Ansell JE, Okike ON, et al. The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study. J Thorac Cardiovasc Surg 1988; 95: 538\u201340.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03015662_CR7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1378\/chest.96.1.27","volume":"96","author":"AJ DelRossi","year":"1989","unstructured":"DelRossi AJ, Cernaianu AC, Botros S, Lemole GM, Moore R. Prophylactic treatment of postperfusion bleeding using EACA. Chest 1989; 96: 27\u201330.","journal-title":"Chest"},{"key":"BF03015662_CR8","first-page":"677","volume":"46","author":"P Trinh-duc","year":"1992","unstructured":"Trinh-duc P, Wintrebert P, Boulfroy D, Albat B, Th\u00e9venet A, Roquefeuil B. Comparaison des effets de l\u2019acide \u03b5aminocapro\u00efque et de l\u2019aprotinine sur le saignement per- et post-op\u00e9ratoire en chirurgie cardiaque. Ann Chir 1992; 46: 677\u201383.","journal-title":"Ann Chir"},{"key":"BF03015662_CR9","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0022-5223(19)34881-0","volume":"103","author":"TM Yau","year":"1992","unstructured":"Yau TM, Carson S, Weisel RD, et al. The effect of warm heart surgery on postoperative bleeding. J Thorac Cardiovasc Surg 1992; 103: 1155\u201363.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03015662_CR10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2165\/00003495-198529030-00003","volume":"29","author":"M Verstraete","year":"1985","unstructured":"Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs 1985; 29: 236\u201361.","journal-title":"Drugs"},{"key":"BF03015662_CR11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0022-5223(19)35634-X","volume":"99","author":"JC Horrow","year":"1990","unstructured":"Horrow JC, Hlavacek J, Strong MD, et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc Surg 1990; 99: 70\u20134.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03015662_CR12","doi-asserted-by":"crossref","first-page":"A986","DOI":"10.1097\/00000542-199109001-00985","volume":"75","author":"J Horrow","year":"1991","unstructured":"Horrow J, Van Riper D, Parmet J, Whooley P. What dose of tranexamic acid is optimally hemostatic? Anesthesiology 1991;75: A986.","journal-title":"Anesthesiology"},{"key":"BF03015662_CR13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/1053-0770(93)90165-H","volume":"7","author":"JM Karski","year":"1993","unstructured":"Karski JM, Teasdale SJ, Norman PH, Carroll JA, Weisel RD, Glynn MFX. Prevention of postbypass bleeding with tranexamic acid and \u03b5-aminocaproic acid. J Cardiothorac Vasc Anesth 1993; 7: 431\u20135.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"BF03015662_CR14","doi-asserted-by":"crossref","first-page":"A139","DOI":"10.1007\/BF03008644","volume":"39","author":"JM Karski","year":"1992","unstructured":"Karski JM, Teasdale SJ, Norman P, et al. Reduction of post cardiopulmonary bypass bleeding with tranexamic acid. Can J Anaesth 1992; 39: A139.","journal-title":"Can J Anaesth"},{"key":"BF03015662_CR15","first-page":"A41","volume":"41","author":"JM Karski","year":"1994","unstructured":"Karski JM, Joiner R, Carroll J, et al. Comparison of the effect of 3 different doses of tranexamic acid on postoperative bleeding in cardiac surgery performed without active systemic cooling. Can J Anaesth 1994; 41: A41.","journal-title":"Can J Anaesth"},{"key":"BF03015662_CR16","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0140-6736(87)91190-1","volume":"II","author":"D Royston","year":"1987","unstructured":"Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987; II: 1289\u201391.","journal-title":"Lancet"},{"key":"BF03015662_CR17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0003-4975(10)62153-4","volume":"44","author":"W Oeveren van","year":"1987","unstructured":"van Oeveren W, Jansen NJG, Bidstrup BP, et al. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg 1987; 44: 640\u20135.","journal-title":"Ann Thorac Surg"},{"key":"BF03015662_CR18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0003-4975(10)66857-9","volume":"48","author":"F Alajmo","year":"1989","unstructured":"Alajmo F, Calamai G, Perna AM, et al. High-dose aprotinin: hemostatic effects in open heart operations. Ann Thorac Surg 1989; 48: 536\u20139.","journal-title":"Ann Thorac Surg"},{"key":"BF03015662_CR19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-5223(19)34573-8","volume":"97","author":"BP Bidstrup","year":"1989","unstructured":"Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 1989; 97: 364\u201372.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03015662_CR20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-2007-1013915","volume":"37","author":"W Dietrich","year":"1989","unstructured":"Dietrich W, Barankay A, Dilthey G, et al. Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application \u2014 clinical experience in 152 cardiac surgical patients. Thorac Cardiovasc Surgeon 1989; 37: 92\u20138.","journal-title":"Thorac Cardiovasc Surgeon"},{"key":"BF03015662_CR21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/s-2007-1013914","volume":"37","author":"G Fraedrich","year":"1989","unstructured":"Fraedrich G, Weber C, Bernard C, Hettwer A, Schlosser V. Reduction of blood transfusion requirement in open heart surgery by administration of high doses of aprotinin \u2014 preliminary results. Thorac Cardiovasc Surgeon 1989; 37: 89\u201391.","journal-title":"Thorac Cardiovasc Surgeon"},{"key":"BF03015662_CR22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/1010-7940(89)90114-0","volume":"3","author":"Ch RH Wildevuur","year":"1989","unstructured":"Wildevuur Ch RH, Eijsman L, Roozendaal KJ, Harder MP, Chang M, van Oeveren W. Platelet preservation during cardiopulmonary bypass with aprotinin. Eur J Cardiothorac Surg 1989; 3: 533\u20138.","journal-title":"Eur J Cardiothorac Surg"},{"key":"BF03015662_CR23","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/00000542-199012000-00009","volume":"73","author":"W Dietrich","year":"1990","unstructured":"Dietrich W, Spannagl M, Jochum M, et al. Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. Anesthesiology 1990; 73: 1119\u201326.","journal-title":"Anesthesiology"},{"key":"BF03015662_CR24","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-5223(19)36893-X","volume":"99","author":"W Oeveren van","year":"1990","unstructured":"van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CRH. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 99: 788\u201397.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03015662_CR25","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0022-5223(19)36611-5","volume":"101","author":"B Blauhut","year":"1991","unstructured":"Blauhut B, Gross C, Necek S, Doran JE, Sp\u00e4th P, Lundsgaard-Hansen P. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991; 101: 958\u201367.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03015662_CR26","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/0003-4975(91)91009-K","volume":"51","author":"MP Harder","year":"1991","unstructured":"Harder MP, Eijsman L, Roozendaal KJ, van Oeveren W, Wildevuur CRH. Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass. Ann Thorac Surg 1991; 51: 936\u201341.","journal-title":"Ann Thorac Surg"},{"key":"BF03015662_CR27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0022-5223(19)36612-7","volume":"101","author":"M Havel","year":"1991","unstructured":"Havel M, Teufelsbauer H, Kn\u00f6bl P, et al. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation. J Thorac Cardiovasc Surg 1991; 101: 968\u201372.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03015662_CR28","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0022-5223(19)36879-5","volume":"102","author":"T Carrel","year":"1991","unstructured":"Carrel T, Bauer E, Laske A, von Segesser L, Turina M. Low-dose aprotinin also allows reduction of blood loss after cardiopulmonary bypass (Letter). J Thorac Cardiovasc Surg 1991; 102: 801.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03015662_CR29","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/0003-4975(92)90089-M","volume":"54","author":"JPAM Sch\u00f6nberger","year":"1992","unstructured":"Sch\u00f6nberger JPAM, Everts PAM, Ercan H, et al. Lowdose aprotinin in internal mammary artery bypass operations contributes to important blood saving. Ann Thorac Surg 1992; 54: 1172\u20136.","journal-title":"Ann Thorac Surg"},{"key":"BF03015662_CR30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF03009699","volume":"40","author":"J-F Hardy","year":"1993","unstructured":"Hardy J-F, Desroches J, B\u00e9lisle S, Perrault J, Carrier M, Robitaille D. Low dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients. Can J Anaesth 1993; 40: 625\u201331.","journal-title":"Can J Anaesth"},{"key":"BF03015662_CR31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF03007591","volume":"38","author":"J-F Hardy","year":"1991","unstructured":"Hardy J-F, Perrault J, Tremblay N, Robitaille D, Blain R, Carrier M. The stratification of cardiac surgical procedures according to use of blood products: a retrospective analysis of 1480 cases. Can J Anaesth 1991; 38: 511\u20137.","journal-title":"Can J Anaesth"},{"key":"BF03015662_CR32","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00000542-199109000-00008","volume":"75","author":"J Boldt","year":"1991","unstructured":"Boldt J, Zickmann B, Czeke A, Herold C, Dapper F, Hempelmann G. Blood conservation techniques and platelet function in cardiac surgery. Anesthesiology 1991; 75: 426\u201332.","journal-title":"Anesthesiology"},{"key":"BF03015662_CR33","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/0003-4975(93)90269-N","volume":"55","author":"J Boldt","year":"1993","unstructured":"Boldt J, Knothe C, Zickmann B, Bill S, Dapper F, Hempelmann G. Platelet function in cardiac surgery: influence of temperature and aprotinin. Ann Thorac Surg 1993; 55: 652\u20138.","journal-title":"Ann Thorac Surg"},{"key":"BF03015662_CR34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0022-5223(12)70102-2","volume":"107","author":"JM Murkin","year":"1994","unstructured":"Murkin JM, Lux J, Shannon NA, et al. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J Thorac Cardiovasc Surg 1994; 107: 554\u201361.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03015662_CR35","first-page":"1471","volume":"86","author":"P Bertrand","year":"1993","unstructured":"Bertrand P, Mazzucotelli JP, Loisance D, Elsayed A, Deleuze P, Cachera JP. L\u2019aprotinine en chirurgie cardiaque chez les patients sous antiagr\u00e9gants plaquettaires. Arch Mal Coeur Vaiss 1993; 86: 1471\u20134.","journal-title":"Arch Mal Coeur Vaiss"},{"key":"BF03015662_CR36","doi-asserted-by":"crossref","first-page":"A33","DOI":"10.1007\/BF03015648","volume":"41","author":"JM Murkin","year":"1994","unstructured":"Murkin JM, McKenzie FN, White S, Shannon NA. A randomized comparison of the efficacy of high or low dose aprotinin, or tranexamic acid, to decrease blood loss and transfusion requirements in aspirin-treated cardiac surgical patients. Can J Anaesth 1994; 41: A33.","journal-title":"Can J Anaesth"},{"key":"BF03015662_CR37","doi-asserted-by":"crossref","first-page":"A80","DOI":"10.1097\/00000542-199109001-00080","volume":"75","author":"C Isetta","year":"1991","unstructured":"Isetta C, Samat C, Kotaiche M, Jourdan J, Grimaud D. Low dose aprotinin or tranexamic acid treatment in cardiac surgery. Anesthesiology 1991; 75: A80.","journal-title":"Anesthesiology"},{"issue":"E","key":"BF03015662_CR38","first-page":"117E","volume":"9","author":"A Hamilton","year":"1993","unstructured":"Hamilton A, Entwistle L, Koshal A, Finegan B. A randomized trial of aprotinin and tranexamic acid comparing their cost and effect on blood component use in repeat cardiac surgery (Abstract). Can J Cardiol 1993; 9 (Suppl E): 117E.","journal-title":"Can J Cardiol"},{"key":"BF03015662_CR39","doi-asserted-by":"crossref","first-page":"A46","DOI":"10.1007\/BF03015648","volume":"41","author":"JM Murkin","year":"1994","unstructured":"Murkin JM, McKenzie FN, White S, Shannon NA. Blood loss in patients undergoing repeat median sternotomy randomized to either high or low dose aprotinin, or tranexamic acid. Can J Anaesth 1994; 41: A46.","journal-title":"Can J Anaesth"},{"key":"BF03015662_CR40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0003-4975(93)90271-I","volume":"55","author":"H Tatar","year":"1993","unstructured":"Tatar H, Cicek S, Demirkilic U, et al. Topical use of aprotinin in open heart operations. Ann Thorac Surg 1993; 55: 659\u201361.","journal-title":"Ann Thorac Surg"},{"key":"BF03015662_CR41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/jama.1991.03460010086037","volume":"265","author":"LT Goodnough","year":"1991","unstructured":"Goodnough LT, Johnston MFM, Toy PTCY, and the Transfusion Medicine Academic Award Group. The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991; 265: 86\u201390.","journal-title":"JAMA"},{"key":"BF03015662_CR42","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0003-4975(92)90066-D","volume":"54","author":"DM Cosgrove","year":"1992","unstructured":"Cosgrove DM III, Heric B, Lytle BW, et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg 1992; 54: 1031\u20138.","journal-title":"Ann Thorac Surg"},{"key":"BF03015662_CR43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0022-5223(19)33850-4","volume":"105","author":"E \u00d8vrum","year":"1993","unstructured":"\u00d8vrum E, Holen EA, Abdelnoor M, \u00d8ystese R, Lindstein Ringdal M. Tranexamic acid (Cyclokapron) is not necessary to reduce blood loss after coronary artery bypass operations. J Thorac Cardiovasc Surg 1993; 105: 78\u201383.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03015662_CR44","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0003-4975(93)90272-J","volume":"55","author":"DM Najman","year":"1993","unstructured":"Najman DM, Walenga JM, Fareed J, Pifarr\u00e9 R. Effects of aprotinin on anticoagulant monitoring: implications in cardiovascular surgery. Ann Thorac Surg 1993; 55: 662\u20136.","journal-title":"Ann Thorac Surg"},{"key":"BF03015662_CR45","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/0003-4975(93)91082-X","volume":"55","author":"TM Sundt","year":"1993","unstructured":"Sundt TM III, Kouchoukos NT, Saffitz JE, Murphy SF, Wareing TH, Stahl DJ. Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest. Ann Thorac Surg 1993; 55: 1418\u201324.","journal-title":"Ann Thorac Surg"},{"key":"BF03015662_CR46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-5223(19)33859-0","volume":"105","author":"BP Bidstrup","year":"1993","unstructured":"Bidstrup BP, Underwood SR, Sapsford RN. Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency. J Thorac Cardiovasc Surg 1993; 105: 147\u201353.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03015662_CR47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-5223(94)70101-6","volume":"107","author":"JH Lemmer","year":"1994","unstructured":"Lemmer JH Jr, Stanford W, Bonney SL, et al. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. J Thorac Cardiovasc Surg 1994; 107: 543\u201353.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03015662_CR48","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0022-5223(94)70336-1","volume":"107","author":"M Havel","year":"1994","unstructured":"Havel M, Grabenw\u00f6ger F, Schneider J, et al. Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood. J Thorac Cardiovasc Surg 1994; 107: 807\u201310.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03015662_CR49","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0003-4975(93)90128-5","volume":"55","author":"BP Bidstrup","year":"1993","unstructured":"Bidstrup BP, Harrison J, Royston D, Taylor KM, Treasure T. Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg 1993; 55: 971\u20136.","journal-title":"Ann Thorac Surg"},{"key":"BF03015662_CR50","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0003-4975(90)90707-D","volume":"50","author":"WJ Scott","year":"1990","unstructured":"Scott WJ, Kessler R, Wernly JA. Blood conservation in cardiac surgery. Ann Thorac Surg 1990; 50: 843\u201351.","journal-title":"Ann Thorac Surg"}],"container-title":["Canadian Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03015662.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03015662\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03015662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T21:45:22Z","timestamp":1589751922000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03015662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1994,11]]}},"alternative-id":["BF03015662"],"URL":"https:\/\/doi.org\/10.1007\/bf03015662","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,11]]}}}